BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32444945)

  • 1. Clinical Practice and Research in Cardio-Oncology: Finding the "Rosetta Stone" for Establishing Program Excellence in Cardio-oncology.
    Adusumalli S; Alvarez-Cardona J; Khatana SM; Mitchell JD; Blaes AH; Casselli SJ; O'Quinn R; Lenihan DJ
    J Cardiovasc Transl Res; 2020 Jun; 13(3):495-505. PubMed ID: 32444945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Imaging in Oncology Patients in Europe: a Model for Advancement of CV Safety and Development of Comprehensive CV Care.
    López-Fernández T
    J Cardiovasc Transl Res; 2020 Jun; 13(3):490-494. PubMed ID: 32583314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Biomarkers in Cardio-Oncology.
    Ananthan K; Lyon AR
    J Cardiovasc Transl Res; 2020 Jun; 13(3):431-450. PubMed ID: 32642841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
    Thuny F; Huttin O; Ederhy S
    Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular medicine and cardio-oncology - A new, evolving clinical frontier.
    Versmissen J; Power JR; Moslehi J
    Vasc Med; 2020 Jun; 25(3):205-207. PubMed ID: 32539631
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardio-Oncology Programs Strive to Balance Cancer Care With Heart Health.
    Hampton T
    Circulation; 2016 Jul; 134(4):353-4. PubMed ID: 27462055
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-Oncology in 2020: Prime for Translation.
    Barac A
    J Cardiovasc Transl Res; 2020 Jun; 13(3):345-346. PubMed ID: 32495266
    [No Abstract]   [Full Text] [Related]  

  • 11. A cardio-oncology experience in Italy: results of a Tuscany regional-based survey.
    Canale ML; Camerini A; Magnacca M; Casolo G;
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):135-40. PubMed ID: 24553090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
    Guha A; Armanious M; Fradley MG
    Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI in cardio-oncology: A review of cardiac complications in oncologic care.
    Jeong D; Gladish G; Chitiboi T; Fradley MG; Gage KL; Schiebler ML
    J Magn Reson Imaging; 2019 Nov; 50(5):1349-1366. PubMed ID: 31448472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Cardio-Oncology: a Systems-Based Perspective on Cardiotoxicity of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.
    Brown SA; Ray JC; Herrmann J
    J Cardiovasc Transl Res; 2020 Jun; 13(3):402-416. PubMed ID: 32253744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for Cardio-Oncology Units.
    Nhola LF; Villarraga HR
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):583-589. PubMed ID: 28330611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardio-Oncology Services: rationale, organization, and implementation.
    Lancellotti P; Suter TM; López-Fernández T; Galderisi M; Lyon AR; Van der Meer P; Cohen Solal A; Zamorano JL; Jerusalem G; Moonen M; Aboyans V; Bax JJ; Asteggiano R
    Eur Heart J; 2019 Jun; 40(22):1756-1763. PubMed ID: 30085070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
    Sayed N; Ameen M; Wu JC
    Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
    Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B
    Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.